Strategic Partnership with Croma-Pharma GmbH
Exclusive Canadian Distribution Partner
Renellence is proud to partner with Croma-Pharma GmbH to bring high-quality European aesthetic solutions to the Canadian market. As a global leader in medical aesthetics, Croma's product portfolio is supported by regulatory approvals in both Canada and the EU.
Introducing the Saypha® Filler Portfolio
Industry-Leading Regulatory Compliance
CE-marked under MDR 2017/745
The first filler lines in the world to meet the rigorous new European Medical Device Regulation standards.
Health Canada Approved
Authorized as a Class III medical device, meeting Canada's highest standards for injectable medical aesthetics.
Why Clinics Choose Renellence
Premium European Products
Access to sophisticated European aesthetic technologies with proven clinical performance and safety profiles
Clinically Validated
Products that meet the highest international safety standards with extensive clinical documentation and testing
Boutique Service
Agile, personalized support that adapts to each clinic's unique needs, challenges, and growth objectives
Responsive Partnership
Direct access to decision-makers and experts who provide ongoing support throughout your practice journey
Training & Resources
Comprehensive education and clinical training tailored to practitioners at every experience level
Reasonable Pricing
Premium European products at competitive price points that make excellence accessible for your practice
Partnerships
We collaborate with leading organizations in the aesthetics field to bring you the best products and services.
The Science Behind Excellence
Advanced Hyaluronic Acid Technology
Saypha® fillers utilize sophisticated cross-linking technology to create products with optimal viscoelastic properties, longevity, and tissue integration, providing natural-looking results for your patients.
The MDR Advantage
Products certified under the new European Medical Device Regulation (MDR 2017/745) undergo rigorous clinical evaluation, enhanced quality management, and comprehensive post-market surveillance, offering practitioners unprecedented confidence.
Clinical Excellence
Backed by robust clinical data, extensive post-market surveillance, and stringent quality control processes.
The Renellence Story
Our name embodies our mission: a fusion of Renatus (rebirth) and Excellence, representing our commitment to renewing standards in medical aesthetics. Founded by Canadian industry veterans with decades of combined experience, Renellence was created to bring exceptional European technologies to Canadian medical professionals. We believe in building lasting partnerships with clinics and practitioners who share our dedication to clinical excellence, patient safety, and outstanding aesthetic outcomes.
